Preclinical contract research

Customized drug development services

Analysis & Guidance Included. Always.

The convergence of fundamental research and regulatory requirements can be handled elegantly through thoughtful study design, excellent communication and perfect experimental execution.

Schedule a call to learn how IPST can deliver your pre-clinical research on-time and on-budget. Our 25 years of experience will strengthen your drug development pipeline.

Call today +1-819-820-1515 or email our Vice-President, Dan Salvail, Ph.D. at dsalvail@ipstherapeutique.com

Let’s get the conversation started.

Dedicated to scientific excellence since 1999, IPS Therapeutique (IPST) specializes in the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models.

Investigative-toxicology-V2

Reduce your costs of early drug development

De-risking pre-clinical drug candidates for scientists has been the focus of IPS Therapeutique (IPST) for 25 years; every in vivo model has been developed with this dual purpose in mind: confirm and define the conditions for efficacy, and identify early indicators of toxicity.

From proteomics to GLP-compliant safety pharmacology studies, IPST’s scientists understand the impact of attrition on drug discovery and use early detection of failure signals to lower the cost of pre-clinical development.

01 / Cardiovascular

Cardiovascular diseases

We leverage our world-class expertise on cardiovascular diseases, e.g., pulmonary arterial hypertension, myocardial infarction, hemorrhagic shock, acute kidney injury, to craft tailored protocols designed in collaboration with you.
Read More
02 / Inflammatory

Inflammatory disorders

We leverage our world-class expertise on inflammatory disorders, e.g., diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibrosis, cholestatic liver disease, to craft tailored protocols designed in collaboration with you.
Read More
03 / Respiratory

Respiratory diseases

We leverage our world-class expertise on respiratory diseases e.,g., chronic obstructive pulmonary disease, asthma, allergic rhinitis, pulmonary fibrosis, to craft tailored protocols designed in collaboration with you.
Read More
04 / Bleeding

Bleeding disorders

We leverage our world-class expertise on bleeding disorders, e.g., hemophilia, sickle cell anemia, immune thrombocytopenia, von Willebrand disease, to craft tailored protocols designed in collaboration with you.
Read More

Discover our featured white papers

Learn more about our ongoing scientific research.
Learn more

A strategy to develop a cardiac anti-arrhythmic drug from scratch

by Dany Salvail Ph.D., Vice-President.

Published on June 19, 2023

Read more

Translation

by Dany Salvail Ph.D., Vice-President.

Published on May 9, 2023

Read more